nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A recurrent mass on the big toe
|
Renne, Salvatore L |
|
|
8 |
10 |
p. 868 |
artikel |
2 |
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
|
Barron, Emma |
|
|
8 |
10 |
p. 813-822 |
artikel |
3 |
Correction to Lancet Diabetes Endocrinol 2014; 2: 307–20
|
|
|
|
8 |
10 |
p. e5 |
artikel |
4 |
Correction to Lancet Diabetes Endocrinol 2020; 8: 672–82
|
|
|
|
8 |
10 |
p. e5 |
artikel |
5 |
Correction to Lancet Diabetes Endocrinol 2020; 8: 782–92
|
|
|
|
8 |
10 |
p. e5 |
artikel |
6 |
Cortisol concentrations and mortality from COVID-19
|
Pal, Rimesh |
|
|
8 |
10 |
p. 809 |
artikel |
7 |
Cortisol concentrations and mortality from COVID-19
|
Choy, Kay W |
|
|
8 |
10 |
p. 808 |
artikel |
8 |
Cortisol concentrations and mortality from COVID-19 – Authors' reply
|
Tan, Tricia |
|
|
8 |
10 |
p. 809-810 |
artikel |
9 |
COVID-19 and diabetes: a co-conspiracy?
|
The Lancet Diabetes & Endocrinology, |
|
|
8 |
10 |
p. 801 |
artikel |
10 |
Diabetes in ageing: pathways for developing the evidence base for clinical guidance
|
Munshi, Medha N |
|
|
8 |
10 |
p. 855-867 |
artikel |
11 |
Donna Ryan: bringing people together and making things happen
|
Mitchell, Fiona |
|
|
8 |
10 |
p. 812 |
artikel |
12 |
Draft FDA guidance for assessing the safety of glucose lowering therapies: a missed opportunity?
|
Khunti, Kamlesh |
|
|
8 |
10 |
p. 810-811 |
artikel |
13 |
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials
|
Groop, Per-Henrik |
|
|
8 |
10 |
p. 845-854 |
artikel |
14 |
Metformin in women with type 2 diabetes in pregnancy
|
Bailey, Clifford J |
|
|
8 |
10 |
p. 802-803 |
artikel |
15 |
Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial
|
Feig, Denice S |
|
|
8 |
10 |
p. 834-844 |
artikel |
16 |
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
|
Holman, Naomi |
|
|
8 |
10 |
p. 823-833 |
artikel |
17 |
SGLT2 inhibitors and renal complications in type 1 diabetes
|
Petrie, John R |
|
|
8 |
10 |
p. 803-805 |
artikel |
18 |
The oldest case of osteopetrosis in a human skeleton: exploring the history of rare diseases
|
Gresky, Julia |
|
|
8 |
10 |
p. 806-808 |
artikel |